BioSpace News Archive

Twist Bioscience Corporation announced the closing of its upsized underwritten public offering of 5,339,285 shares of its common stock at a price of $28.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 696,428 shares of common stock in this offering.

Clovis Oncology, Inc. reported financial results for the quarter and year ended December 31, 2019, and provided an update on Clovis’ clinical development programs and regulatory and commercial outlook for 2020..

Feb. 24, 2020 21:01 UTC -- Management to Host Conference Call at 4:30 p.m. ET Today -- MONROVIA, Calif.--( BUSINESS WIRE )-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a review of recent business and clinical highlights. “Throughout 2019 we

Feb. 24, 2020 21:03 UTC Fourth Quarter Highlights Net sales of $121.5 million, an increase of 0.3% compared to prior year period and 0.9% on a constant currency basis Kevin Kenny, an experienced spine executive, joins as Global Spine President FDA approval of next generation Bone Growth Therapy patient monitoring app STIM onTrack 2.1 Fiscal Year 2019 Highlights Net sales of $460.0 million, an increase of 1.5% compared to prior year and 2.6% o

BEDMINSTER, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Monday, March 9, 2020 at 8:00 a.m. ET to discuss operational and financial results for the fourth quarter and full year ended December 31, 2019. To participate in the call, please dial (877) 407-5976 (domestic) or (412)

BERKELEY, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is scheduled to present at the Cowen and Company 40 th Annual Health Care Conference in Boston, Massachusetts on Monday, March 2, 2020 at 12:00 pm ET. To access the live webcast and subsequent archived recording of this and other company presentations, please visit the investor section of Aduro’s website at

PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel ® Plus Placental Allograft Membrane, its latest wound care offering to support soft tissue repair. AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds. The pro

OTTAWA , Feb. 24, 2020 /CNW/ - The Canadian Medical Association (CMA) shares the sense of outrage expressed by the Alberta Medical Association (AMA) and is equally concerned with the state of health care in the province. At a time when the health care system is confronted with an aging population with complex health issues, destabilizing access to care is the wrong thing to

A new study marks a significant advance in developing a gene therapy for X-linked retinitis pigmentosa, a hereditary disease that leads to severe sight loss in young males.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, reported its financial results for the quarter and year ended December 31, 2019 and financial guidance for the year ending December 31, 2020.